Monoacylglycerol lipase mod 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
  • ||||||||||  Journal:  Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold. (Pubmed Central) -  Oct 14, 2021   
    In this context, we developed new diphenylsulfide-benzoylpiperidine derivatives characterized by a high enzymatic MAGL inhibition activity in the low nanomolar range, a reversible mechanism of action and selectivity. The three most active compounds (15-17) induced an appreciable inhibition of cell viability in a panel of nine cancer cell lines, with IC values ranging between 0.32 and 10 μM, thus highlighting their potential as novel anticancer agents.
  • ||||||||||  Journal:  A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase. (Pubmed Central) -  Jul 28, 2021   
    The assay was validated for the identification and characterization of MAGL modulators using the well-known MAGL inhibitor JZL184. The use of PLG2 displaying distinct bioluminescence color and kinetics may offer a highly desirable opportunity to extend the range of applications to cell-based assays.